Skip to main navigation Skip to search Skip to main content

A site assessment tool for inpatient controlled human infection models for enteric disease pathogens

  • Chad K. Porter*
  • , Katherine J. Detizio
  • , Nicole Maier
  • , Kayla J. Testa
  • , Kawsar R. Talaat
  • , Wilbur H. Chen
  • , Caroline E. Lyon
  • , Ramiro L. Gutierrez
  • , Robert Frenck
  • , Sandra D. Isidean
  • , Robert W. Kaminski
  • , Ashley N. Alcala
  • , Kurt Hanevik
  • , Frederick Sawe
  • , Beth D. Kirkpatrick
  • , A. Louis Bourgeois
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The use of the controlled human infection model to facilitate product development and to advance understanding of host-pathogen interactions is of increasing interest. While administering a virulent (or infective) organism to a susceptible host necessitates an ongoing evaluation of safety and ethical considerations, a central theme in conducting these studies in a safe and ethical manner that yields actionable data is their conduct in facilities well-suited to address their unique attributes. To that end, we have developed a framework for evaluating potential sites in which to conduct inpatient enteric controlled human infection model to ensure consistency and increase the likelihood of success.

Original languageEnglish
Pages (from-to)116-118
Number of pages3
JournalClinical Trials
Volume19
Issue number1
DOIs
StatePublished - Feb 2022

Keywords

  • Controlled human infection models
  • diarrheal disease
  • enteric infection
  • vaccine

Fingerprint

Dive into the research topics of 'A site assessment tool for inpatient controlled human infection models for enteric disease pathogens'. Together they form a unique fingerprint.

Cite this